RxDoctor Payments Data

Tonya Devaul

Nurse Practitioner · Toledo, OHNPI 1154869766

Payments from drug & device makers

$1,462in general payments, 2019–2025

Across 85 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$644
  • Johnson & Johnson$169
  • Takeda Pharmaceuticals U.S.A., Inc.$109
  • Regeneron Healthcare Solutions, Inc.$86
  • Madrigal Pharmaceuticals$82
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$73
  • plus $299 from 7 others

What the payments were for

  • Food & beverage$1,462100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,462 in reported general payments places this provider in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$88,314
Medicare patients
490
Services billed
888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase28$110,451
IbsrelaTenapanor Hcl32$56,460
LinzessLinaclotide49$41,659
XifaxanRifaximin14$33,053
MovantikNaloxegol Oxalate24$13,564
Omeprazole725$9,468
Colestipol Hcl83$7,137
MotegrityPrucalopride Succinate12$6,704
Sucralfate46$3,985
Pantoprazole Sodium298$3,515
Esomeprazole Magnesium43$2,976
Dicyclomine Hcl143$2,404
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl83$1,101
ConstuloseLactulose24$1,051
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl74$1,027

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$644$152,11077 claims
Ardelyx, Inc.Ibsrela$65$56,46032 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$73$33,05314 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$109$6,70412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →